{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:09:23Z","timestamp":1766167763602,"version":"3.48.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03578-3","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:49:22Z","timestamp":1747453762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combining ranibizumab with calcium dobesilate to reduce injection frequency in diabetic macular edema treatment"],"prefix":"10.1007","volume":"45","author":[{"given":"Jian-Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sum-Yuet","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Zhao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo-Shuo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Xiao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"issue":"4","key":"3578_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, Jonas J, Larsen M, Tadayoni R, Loewenstein A (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Int J Ophthalmol 237(4):185\u2013222. https:\/\/doi.org\/10.1159\/000458539","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"3578_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O\u2019Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"issue":"9","key":"3578_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamaophthalmol.2016.2213","volume":"134","author":"G Rees","year":"2016","unstructured":"Rees G, Xie J, Fenwick EK, Sturrock BA, Finger R, Rogers SL, Lim L, Lamoureux EL (2016) Association between diabetes-related eye complications and symptoms of anxiety and depression. JAMA Ophthalmol 134(9):1007\u20131014. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.2213","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3578_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1167\/iovs.11-8992","volume":"53","author":"EK Fenwick","year":"2012","unstructured":"Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL (2012) The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Investig Ophthalmol Vis Sci 53(2):677\u2013684. https:\/\/doi.org\/10.1167\/iovs.11-8992","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"3578_CR5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","volume":"123","author":"JA Wells","year":"2016","unstructured":"Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW (2016) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology 123(6):1351\u20131359. https:\/\/doi.org\/10.1016\/j.ophtha.2016.02.022","journal-title":"Ophthalmology"},{"key":"3578_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.diabres.2016.09.015","volume":"121","author":"T Granstr\u00f6m","year":"2016","unstructured":"Granstr\u00f6m T, Forsman H, Lindholm Olinder A, Gkretsis D, Eriksson JW, Granstam E, Leksell J (2016) Patient-reported outcomes and visual acuity after 12\u00a0months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting. Diabetes Res Clin Pract 121:157\u2013165. https:\/\/doi.org\/10.1016\/j.diabres.2016.09.015","journal-title":"Diabetes Res Clin Pract"},{"key":"3578_CR7","doi-asserted-by":"publisher","first-page":"637021","DOI":"10.3389\/fcvm.2021.637021","volume":"8","author":"J Deng","year":"2021","unstructured":"Deng J, Cai X, Hao M, Liu X, Chen Z, Li H, Liu J, Liao Y, Fu H, Chen H, Qin G, Yan D (2021) Calcium dobesilate (CaD) attenuates high glucose and high lipid-induced impairment of sarcoplasmic reticulum calcium handling in cardiomyocytes. Front Cardiovasc Med 8:637021. https:\/\/doi.org\/10.3389\/fcvm.2021.637021","journal-title":"Front Cardiovasc Med"},{"key":"3578_CR8","doi-asserted-by":"publisher","first-page":"110798","DOI":"10.1016\/j.biopha.2020.110798","volume":"132","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zuo B, Wang N, Li S, Liu C, Sun D (2020) Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1\/p53 signaling pathway. Biomed Pharmacother 132:110798. https:\/\/doi.org\/10.1016\/j.biopha.2020.110798","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3578_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0003319707305407","volume":"59","author":"F Flota-Cervera","year":"2008","unstructured":"Flota-Cervera F, Flota-Ruiz C, Trevi\u00f1o C, Berber A (2008) Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease. Angiology 59(3):352\u2013356. https:\/\/doi.org\/10.1177\/0003319707305407","journal-title":"Angiology"},{"issue":"9","key":"3578_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/02713683.2017.1302591","volume":"42","author":"C Sol\u00e0-Adell","year":"2017","unstructured":"Sol\u00e0-Adell C, Bogdanov P, Hern\u00e1ndez C, Sampedro J, Valeri M, Garcia-Ramirez M, Pasquali C, Sim\u00f3 R (2017) Calcium dobesilate prevents neurodegeneration and vascular leakage in experimental diabetes. Curr Eye Res 42(9):1273\u20131286. https:\/\/doi.org\/10.1080\/02713683.2017.1302591","journal-title":"Curr Eye Res"},{"issue":"10","key":"3578_CR11","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.jdiacomp.2017.07.009","volume":"31","author":"P Bogdanov","year":"2017","unstructured":"Bogdanov P, Sol\u00e0-Adell C, Hern\u00e1ndez C, Garc\u00eda-Ram\u00edrez M, Sampedro J, Sim\u00f3-Servat O, Valeri M, Pasquali C, Sim\u00f3 R (2017) Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db\/db mice. J Diabetes Complicat 31(10):1481\u20131490. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.07.009","journal-title":"J Diabetes Complicat"},{"issue":"3","key":"3578_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000478784","volume":"58","author":"P Voabil","year":"2017","unstructured":"Voabil P, Liberal J, Leal EC, Bauer J, Cunha-Vaz J, Santiago AR, Ambr\u00f3sio AF (2017) Calcium dobesilate is protective against inflammation and oxidative\/nitrosative stress in the retina of a type 1 diabetic rat model. Ophthalmic Res 58(3):150\u2013161. https:\/\/doi.org\/10.1159\/000478784","journal-title":"Ophthalmic Res"},{"issue":"2","key":"3578_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/dmrr.487","volume":"21","author":"E Padilla","year":"2005","unstructured":"Padilla E, Ganado P, Sanz M, Zeini M, Ruiz E, Trivi\u00f1o A, Ram\u00edrez AI, Salazar JJ, Ram\u00edrez JM, Rojas B, Hoz R, Tejerina T (2005) Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 21(2):132\u2013142. https:\/\/doi.org\/10.1002\/dmrr.487","journal-title":"Diabetes Metab Res Rev"},{"key":"3578_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","volume":"2","author":"R Lee","year":"2015","unstructured":"Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond, Engl) 2:17. https:\/\/doi.org\/10.1186\/s40662-015-0026-2","journal-title":"Eye Vis (Lond, Engl)"},{"issue":"7","key":"3578_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ophtha.2015.03.024","volume":"122","author":"A Das","year":"2015","unstructured":"Das A, McGuire PG, Rangasamy S (2015) Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 122(7):1375\u20131394. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.024","journal-title":"Ophthalmology"},{"issue":"1","key":"3578_CR16","first-page":"28","volume":"7","author":"K Miller","year":"2018","unstructured":"Miller K, Fortun JA (2018) Diabetic macular edema: current understanding, pharmacologic treatment options, and developing therapies. Asia Pac J Ophthalmol 7(1):28\u201335","journal-title":"Asia Pac J Ophthalmol"},{"issue":"Suppl 6","key":"3578_CR17","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.5301\/ejo.2010.6050","volume":"21","author":"S Scholl","year":"2011","unstructured":"Scholl S, Augustin A, Loewenstein A, Rizzo S, Kupperman B (2011) General pathophysiology of macular edema. Eur J Ophthalmol 21(Suppl 6):S10\u2013S19. https:\/\/doi.org\/10.5301\/ejo.2010.6050","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3578_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000328979","volume":"227","author":"A Bringmann","year":"2012","unstructured":"Bringmann A, Wiedemann P (2012) M\u00fcller glial cells in retinal disease. Int J Ophthalmol 227(1):1\u201319. https:\/\/doi.org\/10.1159\/000328979","journal-title":"Int J Ophthalmol"},{"key":"3578_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, Rothschild PR, Omri S, G\u00e9liz\u00e9 E, Jonet L, Delaunay K, De Kozak Y, Berdugo M, Zhao M, Crisanti P, Behar-Cohen F (2018) Mechanisms of macular edema: beyond the surface. Prog Retinal Eye Res 63:20\u201368. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.006","journal-title":"Prog Retinal Eye Res"},{"issue":"4","key":"3578_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","volume":"37","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 R, Sundstrom JM, Antonetti DA (2014) Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care 37(4):893\u2013899. https:\/\/doi.org\/10.2337\/dc13-2002","journal-title":"Diabetes Care"},{"issue":"4","key":"3578_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.exer.2007.05.008","volume":"85","author":"J Lowe","year":"2007","unstructured":"Lowe J, Araujo J, Yang J, Reich M, Oldendorp A, Shiu V, Quarmby V, Lowman H, Lien S, Gaudreault J, Maia M (2007) Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. Exp Eye Res 85(4):425\u2013430. https:\/\/doi.org\/10.1016\/j.exer.2007.05.008","journal-title":"Exp Eye Res"},{"issue":"11","key":"3578_CR22","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2337\/dc10-0493","volume":"33","author":"P Massin","year":"2010","unstructured":"Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 33(11):2399\u20132405. https:\/\/doi.org\/10.2337\/dc10-0493","journal-title":"Diabetes Care"},{"issue":"4","key":"3578_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","volume":"118","author":"P Mitchell","year":"2011","unstructured":"Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615\u2013625. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.031","journal-title":"Ophthalmology"},{"key":"3578_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajo.2016.02.028","volume":"165","author":"N Rayess","year":"2016","unstructured":"Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, DeCroos FC, Garg SJ, Hsu J (2016) Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept. Am J Ophthalmol 165:88\u201393. https:\/\/doi.org\/10.1016\/j.ajo.2016.02.028","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"3578_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/iae.0000000000002633","volume":"40","author":"NM Bressler","year":"2020","unstructured":"Bressler NM, Beaulieu WT, Bressler SB, Glassman AR, Melia BM, Jampol LM, Jhaveri CD, Salehi-Had H, Velez G, Sun JK (2020) ANTI-vascular endothelial growth factor therapy and risk of traction retinal detachment in eyes with proliferative diabetic retinopathy: pooled analysis of five drcr retina network randomized clinical trials. Retina (Philadelphia, Pa) 40(6):1021\u20131028. https:\/\/doi.org\/10.1097\/iae.0000000000002633","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"12","key":"3578_CR26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/ijg.0000000000001894","volume":"30","author":"AM Levin","year":"2021","unstructured":"Levin AM, Chaya CJ, Kahook MY, Wirostko BM (2021) Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations. J Glaucoma 30(12):1019\u20131026. https:\/\/doi.org\/10.1097\/ijg.0000000000001894","journal-title":"J Glaucoma"},{"issue":"5","key":"3578_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ophtha.2013.11.041","volume":"121","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121(5):1045\u20131053. https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.041","journal-title":"Ophthalmology"},{"issue":"5","key":"3578_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ajo.2014.02.019","volume":"157","author":"O Comyn","year":"2014","unstructured":"Comyn O, Sivaprasad S, Peto T, Neveu MM, Holder GE, Xing W, Bunce CV, Patel PJ, Egan CA, Bainbridge JW, Hykin PG (2014) A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study). Am J Ophthalmol 157(5):960\u2013970. https:\/\/doi.org\/10.1016\/j.ajo.2014.02.019","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"3578_CR29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203. https:\/\/doi.org\/10.1056\/NEJMoa1414264","journal-title":"N Engl J Med"},{"issue":"12","key":"3578_CR30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00417-006-0318-2","volume":"244","author":"ML Ribeiro","year":"2006","unstructured":"Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG (2006) Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. Graefe\u2019s Arch Clin Exp Ophthalmol 244(12):1591\u20131600. https:\/\/doi.org\/10.1007\/s00417-006-0318-2","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3578_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11427-014-4792-1","volume":"58","author":"X Zhang","year":"2015","unstructured":"Zhang X, Liu W, Wu S, Jin J, Li W, Wang N (2015) Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis. Sci China Life Sci 58(1):101\u2013107. https:\/\/doi.org\/10.1007\/s11427-014-4792-1","journal-title":"Sci China Life Sci"},{"issue":"10","key":"3578_CR32","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s10792-021-01914-x","volume":"41","author":"H Ashraf","year":"2021","unstructured":"Ashraf H, Lotfi M, Akbari M, Jahanbani-Ardakani H, Ghaffari M, Khalili MR (2021) Effect of calcium dobesilate on retrobulbar blood flow and choroidal thickness in patients with non-proliferative diabetic retinopathy. Int Ophthalmol 41(10):3479\u20133486. https:\/\/doi.org\/10.1007\/s10792-021-01914-x","journal-title":"Int Ophthalmol"},{"key":"3578_CR33","doi-asserted-by":"publisher","first-page":"6725225","DOI":"10.1155\/2022\/6725225","volume":"2022","author":"D Wang","year":"2022","unstructured":"Wang D, Wang H, Wu S, Yang X, Xu J (2022) Intravitreal ranibizumab alone or in combination with calcium dobesilate for the treatment of diabetic macular edema in nonproliferative diabetic retinopathy patients: 12-month outcomes of a retrospective study. Int J Clin Pract 2022:6725225. https:\/\/doi.org\/10.1155\/2022\/6725225","journal-title":"Int J Clin Pract"},{"issue":"7","key":"3578_CR34","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/iae.0000000000001363","volume":"37","author":"M Lafuente","year":"2017","unstructured":"Lafuente M, Ort\u00edn L, Argente M, Guindo JL, L\u00f3pez-Bernal MD, L\u00f3pez-Rom\u00e1n FJ, Garc\u00eda MJ, Domingo JC, Lajara J (2017) Combined intravitreal ranibizumab and oral supplementation with docosahexaenoic acid and antioxidants for diabetic macular edema: two-year randomized single-blind controlled trial results. Retina (Philadelphia, Pa) 37(7):1277\u20131286. https:\/\/doi.org\/10.1097\/iae.0000000000001363","journal-title":"Retina (Philadelphia, Pa)"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03578-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:23Z","timestamp":1766167523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03578-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03578-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"10 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Jinan University (No:KY-2020-084).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"203"}}